The table below shows Edesa Biotech, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
$0.00
$328.80K
Cost of revenue
-
-
-
-
$0.00
$17.60K
Gross profit
-
-
-
-
-
-
R&D
$3.67M
$2.88M
$4.79M
$13.34M
$17.95M
$3.33M
SG&A
$4.24M
EDSA annual revenue (10-K history)
Edesa Biotech, Inc. reported annual revenue of $0.00 for fiscal year 2021. That is down 100.0% from $328.80K in fiscal 2020. Over the 9 fiscal years shown, annual revenue declined from $286.05K (FY 2012) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.